Personalized Nanovaccine Based on STING-Activating Nanocarrier for Robust Cancer Immunotherapy

0
43
Investigators developed a minimalist nanovaccine that exploits a dual immunofunctional polymeric nanoplatform to encapsulate ovalbumin via electrostatic interaction when the nanocarrier served as both STING agonist and immune adjuvant in dendritic cells.
[ACS Nano]
AbstractGraphical Abstract